BioHealth News Archive
Maryland Today | UMD Ranked in Top 10 for Innovation and Entrepreneurship Education for Sixth Straight Year
For the sixth consecutive year, the University of Maryland (UMD) earned a top 10 ranking in The Princeton Review’s annual survey of top schools…
Read MoreSR One Completes Spin-out from GSK and Closes First Fund at $500 Million | Business | thedailytimes.com
SR One, a trans-Atlantic biotech venture capital firm, announced today the close of its first independent fund, having recently completed its spinout from GlaxoSmithKline…
Read MoreThe state of AI in 2020 | McKinsey
The results of this year’s McKinsey Global Survey on artificial intelligence (AI) suggest that organizations are using AI as a tool for generating value.…
Read MoreProtecting Our Future: Spurring Innovation to Support Pediatric Preparedness
With COVID-19, we’ve seen our preparedness response tested, and the question remains, how can we be better prepared to protect some of the most…
Read MoreBLUE KNIGHT™ Symposium
In seeking to combat emerging infectious diseases and other 21st century health threats, the path to better prepared, protected, and healthy individuals, families, and…
Read MoreJoin the Force: An Info Session on JLABS @ Washington, DC and the BLUE KNIGHT™ Collaboration
BLUE KNIGHT™, a collaboration between Johnson & Johnson Innovation – JLABS and the Biomedical Advanced Research and Development Authority (BARDA), offers emerging life science…
Read MorePrivate S. Korean investments in biohealth to reach 10 trillion won by 2023 – EconoTimes
South Korea’s leading biologics companies will invest hundreds of billions of won to building additional plants that would push the total amount of private…
Read MoreImmunomic Therapeutics and CoImmune Therapeutics Enter into Partnership to Manufacture ITI-1020, a Novel Experimental Cell Therapy for Glioblastoma | Business Wire
ROCKVILLE, Md. & DURHAM, N.C.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, and CoImmune,…
Read MoreMerck to Acquire Maryland-based OncoImmune’s Promising COVID-19 Drug in $425 Million Deal · BioBuzz
KENILWORTH, N.J., & ROCKVILLE, Md.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, and OncoImmune, a privately-held, clinical-stage biopharmaceutical company,…
Read MoreNORTHPOND VENTURES: Harvard’s Wyss Institute Creates Research And Innovation Alliance With Northpond Labs | Business Wire
BOSTON--(BUSINESS WIRE)--Harvard University's Wyss Institute for Biologically Inspired Engineering has established its first research and innovation alliance by joining forces with Northpond Labs, the…
Read MoreTIME Names Johns Hopkins’ COVID Dashboard A Top Invention Of 2020 – CBS Baltimore
BALTIMORE (WJZ) — TIME Magazine has named the Johns Hopkins University’s COVID-19 dashboard a top invention of 2020. The Johns Hopkins Coronavirus Resource Center…
Read MoreTEDCO, EcoMap are creating the Maryland Entrepreneur Hub for business-building resources – Technical.ly Baltimore
Maryland organizations are building an AI-powered web platform where entrepreneurs can find all of the resources available to them in the state. It’ll be…
Read MoreRegistration for Pantheon 2020 | Recognizing Progress in an Unprecedented Year
Pantheon 2020 on Thursday, December 3, will feature breakout sessions, including "Diversity & Disruption: How 2020 Will Make Life Sciences Stronger". Join us as…
Read MoreAssistant Secretary Robert Kadlec announces new BARDA Director=
I am pleased to announce today the selection of Gary Disbrow, PhD, as Deputy Assistant Secretary for Preparedness and Response and Director of the…
Read MoreAWE Project – Baltimore Accepting Applications thru 11/23
The Achieving Women Enterprise Foundation is offering a local program cosponsored by TEDCO, the Sage Policy Group, and others which includes a 4 day…
Read More